# ConvaTec Group PLC 35.4% potential upside indicated by RBC Capital Markets

- Link: https://www.directorstalkinterviews.com/convatec-group-plc-35.4-potential-upside-indicated-by-rbc-capital-markets/4121127473
- Published: 2023-09-19T13:45:16+01:00
- Author: Charlotte Edwards

**ConvaTec Group PLC** with ticker (LON:CTEC) now has a potential upside of 35.4%
according to RBC Capital Markets.
RBC Capital Markets set a target price of 300 
GBX for the company, which when compared to the ConvaTec Group PLC share price of
222 GBX at opening today (19/09/2023) indicates a potential upside of 35.4%. Trading
has ranged between 196 (52 week low) and 268 (52 week high) with an average of 6,018,736
shares exchanging hands daily. The market capitalisation at the time of writing 
is £4,450,186,845.Convatec Group Plc is a United Kingdom-based medical products 
and technologies company. The Company is engaged in the development, manufacture
and sale of medical products, services, and technologies. It is focused on solutions
for the management of chronic conditions. It markets and sells its solutions and
services in four categories, such as Advanced Wound Care, Ostomy Care, Continence
and Critical Care, and Infusion Care. Its Advanced Wound Care includes advanced 
solutions for the management of acute and chronic wounds resulting from ongoing 
conditions, such as diabetes, and acute conditions resulting from traumatic injury
and burns. Ostomy Care includes devices, accessories and personalized services for
individuals with a stoma. Its Continence and Critical Care includes products and
services for people with urinary continence issues, and other devices for critical
care. Its Infusion Care includes disposable infusion sets used in insulin pump therapy
for people with diabetes.

Share on: